A new treatment under investigation for multiple sclerosis (MS) is safe and tolerable in phase I clinical trials, according to a study published August 27, 2014, in Neurology® Neuroimmunology & Neuroinflammation.
The phase I studies were the first to test the drug candidate in humans. Studies with animals showed that the drug, which is called anti-LINGO-1, or BIIB033, may be able to reverse the demyelination of the nerves. Anti-LINGO-1 blocks LINGO-1, a central nervous system protein that prevents myelination. Current treatments for MS work to reduce new damage to the brain, but do not repair new or past damage...... Read More - http://www.ms-uk.org/emergingtherapies
Researchers investigating new treatment for MS
Researchers investigating new treatment for MS
MS-UK - http://www.ms-uk.org/
-
- Similar Topics
- Replies
- Views
- Last post
-
- 2 Replies
- 938 Views
-
Last post by Petr75
-
- 0 Replies
- 1002 Views
-
Last post by NHE
-
- 5 Replies
- 2211 Views
-
Last post by Jaded
-
- 0 Replies
- 8713 Views
-
Last post by NHE
-
- 0 Replies
- 3872 Views
-
Last post by NHE
-
- 0 Replies
- 2084 Views
-
Last post by Cece
-
- 0 Replies
- 1825 Views
-
Last post by frodo
-
- 0 Replies
- 2296 Views
-
Last post by NHE
-
- 2 Replies
- 994 Views
-
Last post by NHE